Cellular and molecular mechanisms of the selective regulation of IL-12 production by 12/15-lipoxygenase

Journal of Immunology

Volumn 176, Issue 1, 2006, Pages 265-274

  Middleton, Melissa K ^a,b   Rubinstein, Tanya ^a   Puré, Ellen ^a,c  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Ludwig Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; BINDING PROTEIN; CD40 ANTIGEN; CD40 LIGAND; INTERLEUKIN 12; INTERLEUKIN 23; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL TYPE; CLINICAL PATHWAY; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST RESISTANCE; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLAMMATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

EID: 29644436198     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.1.265     Document Type: Article

References (50)

1. Langrish, C. L., B. S. McKenzie, N. J. Wilson, R. de Waal Malefyt, R. A. Kastelein, and D. J. Cua. 2004. IL-12 and IL-23: master regulators of innate and adaptive immunity, Immunol. Rev. 202: 96-105.
2. Schmidt, C., T. Marth, B. M. Willig, A. Hombach, H. Abken, and A. Slallmach. 2002. Interleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease. Pathobiology 70: 177-183.
3. Lee, T. S., H. C. Yen, C. C. Pan, and L. Y. Chau. 1999. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19: 734-742.
4. Podlaski, F. J., V. B. Nanduri, J. D. Hulmes, Y. C. Pan, W. Levin, W. Danho, R. Chizzonite, M. K. Gately, and A. S. Stern. 1992. Molecular characterization of interleukin 12. Arch. Biochem. Biophys. 294: 230-237.
5. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
6. Ozato, K., H. Tsujimura, and T. Tamura. 2002. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. BioTechniques Oct (Suppl.): 66-68.
7. Rader, D. J., and E. Puré. 2005. Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell? Cell Metab. 1: 223-230.
8. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173: 869-879.
9. Hanada, T., and A. Yoshimura. 2002. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13: 413-421.
10. Szekeres, C. K., M. Trikha, D. Nie, and K. V. Honn. 2000. Eicosanoid 12(S)-HETE activates phosphatidylinositol 3-kinase. Biochem. Biophys. Res. Commun. 275: 690-695.
11. Makheja, A. N. 1992. Atherosclerosis: the eicosanoid connection. Mol. Cell. Biochem. 111: 137-142.
12. Conrad, D. J. 1999. The arachidonate 12/15 lipoxygenases. A review of tissue expression and biologic function. Clin. Rev. Allergy Immunol. 17: 71-89.
13. Hedrick, C. C., M. D. Kim, R. D. Natarajan, and J. L. Nadler. 1999. 12-Lipoxygenase products increase monocyte:endothelial interactions. Adv. Exp. Med. Biol. 469: 455-460.
14. Reilly, K. B., S. Srinivasan, M. E. Hatley, M. K. Patricia, J. Lannigan, D. T. Bolick, G. Vandenhoff, H. Pei, R. Natarajan, J. L. Nadler, and C. C. Hedrick. 2004. 12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo. J. Biol. Chem. 279: 9440-9450.
15. Li, S. L., R. S. Dwarakanath, Q. Cai, L. Laming, and R. Natarajan. 2005. Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs. J. Lipid Res. 46: 220-229.
16. Zhao, L., C. A. Cuff, E. Moss, U. Wille, T. Cyrus, E. A. Klein, D. Pratico, D. J. Rader, C. A. Hunter, E. Puré, and C. D. Funk. 2002. Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia. J. Biol. Chem. 277: 35350-35356.
17. Hodge-Dufour. J., P. W. Noble, M. R. Horton, C. Bao, M. Wysoka, M. D. Burdick, R. M. Strieter, G. Trinchieri, and E. Puré. 1997. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J. Immunol. 159: 2492-2500.
18. Bender, J. G., K. L. Unverzagt, P. B. Maples, Y. Mehrotra, J. Mellon, D. E. Van Epps, and C. C. Stewart. 1992. Functional characterization of mouse granulocytes and macrophages produced in vitro from bone marrow progenitors stimulated with interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF). Exp. Hematol. 20: 1135-1140.
19. Son, Y. I., S. Egawa, T. Tatsumi, R. E. Redlinger, Jr., P. Kalinski, and T. Kanto. 2002. A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells. J. Immunol. Methods 262: 145-157.
20. Noorchashm, H., A. Bui, H. L. Li, A. Ealon, L. Mandik-Nayak, C. Sokol, K. M. Potts, E. Puré, and J. Erikson. 1999. Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process. Int. Immunol. 11: 765-776.
21. Levitz, S. M., and R. D. Diamond. 1985. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J. Infect. Dis. 152: 938-945.
22. Lieberman, L. A., F. Cardillo, A. M. Owyang, D. M. Rennick, D. J. Cua, R. A. Kastelein, and C. A. Hunter. 2004. IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. J. Immunol. 173: 1887-1893.
23. Sun, D., and C. D. Funk. 1996. Disruption of 12/15-lipoxygenase expression in peritoneal macrophages: enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein. J. Biol. Chem. 271: 24055-24062.
24. Kielian, T., N. Esen, and E. D. Bearden. 2005. Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan bul not intact bacteria by microglia, Glia 49: 567-576.
25. Reis e Sousa, C., S. Hieny, T. Scharton-Kersten, D. Jankovic, H. Charest, R. N. Germain, and A. Sher. 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186: 1819-1829.
26. Huang, L. Y., C. Reis e Sousa, Y. Itoh, J. Inman, and D. E. Scott. 2001. IL-12 induction by a Th1-inducing adjuvant in vivo: dendritic cell subsets and regulation by IL-10. J. Immunol 167: 1423-1430.
27. Davenport, P., and P. G. Tipping. 2003. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 163: 1117-1125.
28. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
29. Gran, B., G. X. Zhang, and A. Rostami. 2004. Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination. Crit. Rev. Immunol. 24: 111-128.
30. Heydeck, D., L. Thomas, K. Schnurr, F. Trebus, W. E. Thierfelder, J. N. Ihle, and H. Kuhn. 1998. Interleukin-4 and -13 induce upregulation of the murine macrophage 12/15-lipoxygenase activity: evidence for the involvement of transcription factor STAT6. Blood 92: 2503-2510.
31. Li, Y., P. Maher, and D. Schubert. 1997. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19: 453-463.
32. Smith, W. L., E. A. Meade, and D. L. DeWitt. 1994. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. Ann. NY Acatl. Sci. 714: 136-142.
33. Szekeres, C. K., M. Trikha, and K. V. Honn. 2002. 12(S)-HETE, pleiotropic functions, multiple signaling pathways. Adv. Exp. Med. Biol. 507: 509-515.
34. Huang, J. T., J. S. Welch, M. Ricote, C. J. Binder, T. M. Willson, C. Kelly, J. L. Witztum, C. D. Funk, D. Conrad, and C. K. Glass. 1999. Interleukin-4-dependent production of PPAR-γligands in macrophages by 12/15-lipoxygenase. Nature 400: 378-382.
35. Kim, Y. S., M. A. Reddy, L. Lanting, S. G. Adler, and R. Natarajan. 2003. Differential behavior of mesangial cells derived from 12/15-lipoxygenase knock-out mice relative to control mice. Kidney Int. 64: 1702-1714.
36. Reddy, M. A., Y. S. Kim, L. Lanting, and R. Natarajan. 2003. Reduced growth factor responses in vascular smooth muscle cells derived from 12/15-lipoxygenase-deficient mice. Hypertension 41: 1294-1300.
37. Rankin, S. M., S. Parthasarathy, and D. Steinberg. 1991. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J. Lipid Res. 32: 449-456.
38. Wilmanski, J., M. Siddiqi, E. A. Deitch, and Z. Spolarics. 2005. Augmented IL-10 production and redox-dependent signaling pathways in glucose-6-phosphate dehydrogenase-deficient mouse peritoneal macrophages. J. Leukocyte Biol. 78: 85-94.
39. Aramaki, Y., S. Yotsumoto, H. Watanabe, and S. Tsuchiya. 2002. NADPH-oxidase may contribute to IL-12 production in macrophages stimulated with CpG phosphorothioate oligodeoxynucleotides. Biol. Pharm. Bull. 25: 351-355.
40. Matsuzawa, A., K. Saegusa, T. Noguchi, C. Sadamitsu, H. Nishitoh, S. Nagai, S. Koyasu, K. Matsumoto, K. Takeda, and H. Ichijo. 2005. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 6: 587-592.
41. Ma, X., J. M. Chow, G. Gri, G. Carra, F. Gerosa, S. F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J. Exp. Med. 183: 147-157.
42. Wang, I. M., C. Contursi, A. Masumi, X. Ma, G. Trinchieri, and K. Ozato. 2000. An IFN-γ-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J. Immunol. 165: 271-279.
43. Giese, N. A., L. Gabriele, T. M. Doherty, D. M. Klinman, L. Tadesse-Heath, C. Contursi, S. L. Epstein, and H. C. Morse, 3rd. 1997. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J. Exp. Med. 186: 1535-1546.
44. Bradford, M., A. J. Schroeder, H. C. Morse, 3rd, S. N. Vogel, and J. S. Cowdery. 2002. CpG DNA induced IL-12 p40 gene activation is independent of STAT1 activation or production of interferon consensus sequence binding protein. J. Biomed. Sci. 9: 688-696.
45. Sanjabi, S., A. Hoffmann, H. C. Liou, D. Baltimore, and S. T. Smale. 2000. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA 97: 12705-12710.
46. Murphy, T. L., M. G. Cleveland, P. Kulesza, J. Magram, and K. M. Murphy. 1995. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell. Biol. 15: 5258-5267.
47. Romani, L., A. Mencacci, E. Cenci, R. Spaccapelo, G. Del Sero, I. Nicoletti, G. Trinchieri, F. Bistoni, and P. Puccetti. 1997. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J. Immunol. 158: 5349-5356.
48. Vanderlaan, P. A., and C. A. Reardon. 2005. Thematic review series: the immune system and atherogenesis. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis. J. Lipid Res. 46: 829-838.
49. Tsutsui, H., K. Adachi, E. Seki, and K. Nakanishi. 2003. Cytokine-induced inflammatory liver injuries. Curr. Mol. Med. 3: 545-559.
50. Fairweather, D., S. Frisancho-Kiss, S. A. Yusung, M. A. Barrett S. E. Davis, R. A. Steele, S. J. Gatewood, and N. R. Rose. 2005. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-γ and macrophage and neutrophil populations in the heart. J. Immunol. 174: 261-269.